These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7221053)

  • 1. [Evaluation of the reliability of 131I-19-iodocholesterol scintigraphic examination in the diagnosis of adrenal tumors].
    Troncone L; Galli G; Focacci C
    Radiol Med; 1980 Nov; 66(11):841-2. PubMed ID: 7221053
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of 131I-19-iodocholesterol scintigraphy and ultrasonography in the localization of a poorly vascularized phaeochromocytoma.
    Troncone L; Falappa PG; Cavallaro A; Netri G
    Br J Radiol; 1981 Apr; 54(640):353-5. PubMed ID: 7225727
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adrenal scanning using 19-iodocholesterol-I131].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Markov VV; Iakovlev AA
    Vrach Delo; 1979 Jul; (7):32-5. PubMed ID: 473741
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioiodocholesterol scintigraphy in adrenal gland tumors.
    Troncone L
    Eur J Nucl Med; 1980 Aug; 5(4):345-56. PubMed ID: 6249600
    [No Abstract]   [Full Text] [Related]  

  • 5. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-19-iodocholesterol scintigraphy for the localization of medullary tumors.
    Troncone L; Falappa PG; Focacci C; Galli G
    J Nucl Med Allied Sci; 1977; 21(4):159-64. PubMed ID: 604427
    [No Abstract]   [Full Text] [Related]  

  • 7. 131I-6-iodocholesterol, an agent for imaging the adrenal gland.
    Jixiao M; Ruisen Z
    Chin Med J (Engl); 1979 Apr; 92(4):237-46. PubMed ID: 108055
    [No Abstract]   [Full Text] [Related]  

  • 8. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
    Schteingart DE; Seabold JE; Gross MD; Swanson DP
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement in the quality of 19-iodocholesterol-131I scintigraphy by using polysponin].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA
    Med Radiol (Mosk); 1980 Sep; 25(9):14-8. PubMed ID: 7421434
    [No Abstract]   [Full Text] [Related]  

  • 10. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
    Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
    J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
    Reschini E; Catania A
    Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of 131I-19-iodocholesterol by an adrenal cortical carcinoma and its metastases.
    Chatal JF; Charbonnel B; Le Mevel BP; Guihard D
    J Clin Endocrinol Metab; 1976 Jul; 43(1):248-51. PubMed ID: 947944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High thyroid radiation dose associated with 131-I-19-iodocholesterol adrenal scanning.
    O'Connor MK; Cullen MJ; Malone JF
    Br J Radiol; 1979 Feb; 52(614):130-3. PubMed ID: 427363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of pharmacological preparations for the purpose of improving the visualization of the adrenals with 19-iodocholesterol-131I].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA
    Med Radiol (Mosk); 1979 Jan; 24(1):37-41. PubMed ID: 215865
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of a stromal luteoma of the ovary using 131I-iodocholesterol scintigraphy].
    Taillefer R; Levasseur A; Chapdelaine A; Bélanger AB
    Union Med Can; 1981 May; 110(5):435-8. PubMed ID: 6266112
    [No Abstract]   [Full Text] [Related]  

  • 16. Iodocholesterol adrenal scanning for the detection of adrenal metastases in lung cancer and its clinical significance.
    Quraishi MA; Costanzi JJ; Balachandran S
    Cancer; 1981 Aug; 48(3):714-6. PubMed ID: 7248897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-19-iodocholesterol visualization of an adrenal carcinoma without clinical manifestations.
    Bossuyt A; Somers G
    J Nucl Biol Med; 1975; 19(4):225-7. PubMed ID: 1223256
    [No Abstract]   [Full Text] [Related]  

  • 18. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
    Hogan MJ; McRae J; Schambelan M; Biglieri EG
    N Engl J Med; 1976 Feb; 294(8):410-4. PubMed ID: 1246308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localisation of adrenal adenoma with I 131-19 iodocholesterol.
    Dimopoulos C; Ikkos D
    Br J Urol; 1977 Aug; 49(4):256. PubMed ID: 912247
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of adrenal 131-I-19-iodocholesterol scintigraphy in the etiological diagnosis of primary hyperaldosteronism].
    Rodat O; Charbonnel B; Lucas B; Weber M; Donet P; Mitard D; Tellier JL
    Rev Med Interne; 1982; 3(3):257-61. PubMed ID: 7178715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.